This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
protein
product name :
Human REG1B Protein (Recombinant His) - LS-G19794
catalog :
LS-G19794
product information
ProteinId :
19794
CatalogNumber :
LS-G19794
Product Name :
Human REG1B Protein (Recombinant His) - LS-G19794
Description :
The Recombinant Human REG 1 beta manufactured with N-terminal fusion of His Tag. The Human REG 1 beta His-Tagged Fusion Protein, produced in E. coli, is 17.8 kDa protein containing 144 amino acid residues of the Human REG 1 beta and 12 additional amino acid residues - His Tag (underlined).
PresentationDesc :
Lyophilized from 20 mM Tris, pH 8.0
ProteinTag :
His
ProteinType :
Recombinant
ProteinSpecies :
Human
ProteinSourceSpecies :
E. coli
RecommendedStorage :
Store at -20°C. Reconstitute and aliquot at 4°C for short term.
Purification :
Greater than 95% by SDS-PAGE
PredictedMolecularWeight :
17.8 kDa
Gene :
REG1B
StandardGeneSymbol :
REG1B
Synonyms :
REG1B, REG-1-beta, Regenerating protein I beta, REGH, REGL, Lithostathine 1 beta, PSP-2, PSPS2, Lithostathine-1-beta, Pancreatic stone protein 2, REGI-BETA
SalesRegion :
Worldwide
company information

LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
Seattle, WA 98121
antibodies@lsbio.com
https://www.lsbio.com1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.
questions and comments